CD36 and metabolic dysfunction-associated steatotic liver disease: In addition, CD36 transduces signals to mediate its role in inflammation [42] and lipid metabolism, thus accelerating the progression of metabolic diseases including obesity, atherosclerosis, NAFLD, and type 2 diabetes [43].